凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CASI 凯信远达

盘前交易 12-23 05:17:32 EST

2.65

-0.14

-5.02%

最高2.82	最低2.65	成交量7.68万
今开2.72	昨收2.79	日振幅6.09%
总市值3,988万	流通市值1,713万	总股本1,505万
成交额21.17万	换手率1.19%	流通股本646.32万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CASI","market":"US","secType":"STK","nameCN":"凯信远达","latestPrice":2.65,"timestamp":1734728382638,"preClose":2.79,"halted":0,"volume":76817,"delay":0,"floatShares":6463173,"shares":15048505,"eps":-2.228194,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.14,"latestTime":"12-23 05:17:32 EST","open":2.72,"high":2.82,"low":2.65,"amount":211745.092606,"amplitude":0.060932,"askPrice":4.24,"askSize":200,"bidPrice":2.2,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.228194,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":834552000000,"adjPreClose":2.65,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.65,"preClose":2.65,"latestTime":"16:05 EST","volume":72,"amount":198.66,"timestamp":1734728704148},"volumeRatio":2.0083205284999006,"impliedVol":0.7287,"impliedVolPercentile":0.28},"requestUrl":"/m/hq/s/CASI","defaultTab":"news","newsList":[{"id":"2492773172","title":"凯信远达盘中异动 股价大跌6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492773172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492773172?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:10","pubTimestamp":1734621005,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时10分，凯信远达股票出现异动，股价大幅下跌6.64%。截至发稿，该股报2.67美元/股，成交量3458股，换手率0.02%，振幅7.30%。凯信远达股票所在的生物技术行业中，整体跌幅为3.40%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231005a1fb6910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231005a1fb6910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2492415424","title":"凯信远达下跌5.3%，报2.86美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415424","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492415424?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:59","pubTimestamp":1734555567,"startTime":"0","endTime":"0","summary":"12月19日，凯信远达(CASI)盘中下跌5.3%，截至04:59，报2.86美元/股，成交6.54万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/19045946566352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2492960928","title":"凯信远达下跌5.4%，报2.98美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492960928","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492960928?lang=zh_cn&edition=full","pubTime":"2024-12-18 00:44","pubTimestamp":1734453887,"startTime":"0","endTime":"0","summary":"12月18日，凯信远达(CASI)盘中下跌5.4%，截至00:44，报2.98美元/股，成交9.92万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/18004446509022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2492969791","title":"凯信远达盘中异动 大幅拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492969791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492969791?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:15","pubTimestamp":1734448553,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时15分，凯信远达股票出现异动，股价大幅上涨5.42%。截至发稿，该股报3.32美元/股，成交量9306股，换手率0.06%，振幅5.40%。凯信远达股票所在的生物技术行业中，整体涨幅为0.45%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217231553ab7f69ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217231553ab7f69ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2491692451","title":"凯信远达盘中异动 早盘急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692451?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:41","pubTimestamp":1734360108,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时41分，凯信远达股票出现波动，股价急速上涨5.14%。截至发稿，该股报3.27美元/股，成交量4293股，换手率0.03%，振幅4.18%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.41%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224148ab7c9952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224148ab7c9952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2491748375","title":"凯信远达盘中异动 早盘大幅上涨6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491748375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491748375?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:39","pubTimestamp":1734100753,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时39分，凯信远达股票出现异动，股价大幅拉升6.84%。截至发稿，该股报3.28美元/股，成交量1907股，换手率0.01%，振幅0.03%。凯信远达股票所在的生物技术行业中，整体跌幅为0.24%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223913ab759066&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223913ab759066&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2491351323","title":"凯信远达上涨2.4%，报3.195美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491351323","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491351323?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:06","pubTimestamp":1734019615,"startTime":"0","endTime":"0","summary":"12月13日，凯信远达(CASI)盘中上涨2.4%，截至00:06，报3.195美元/股，成交4.29万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/13000646338777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2490387163","title":"凯信远达盘中异动 早盘快速拉升7.05%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490387163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490387163?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:31","pubTimestamp":1734013864,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时31分，凯信远达股票出现异动，股价急速拉升7.05%。截至发稿，该股报3.34美元/股，成交量1067股，换手率0.01%，振幅5.77%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体跌幅为0.10%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223104a1e95010&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223104a1e95010&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2490868212","title":"凯信远达下跌6.79%，报3.197美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868212","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490868212?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:34","pubTimestamp":1733927694,"startTime":"0","endTime":"0","summary":"12月11日，凯信远达(CASI)开盘下跌6.79%，截至22:34，报3.197美元/股，成交1.74万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/11223446284912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2490635398","title":"凯信远达盘中异动 大幅跳水6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490635398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490635398?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:34","pubTimestamp":1733927677,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时34分，凯信远达股票出现波动，股价快速下挫6.79%。截至发稿，该股报3.20美元/股，成交量1216股，换手率0.01%，振幅5.25%。凯信远达股票所在的生物技术行业中，整体涨幅为0.00%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121122343795e8f836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121122343795e8f836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2490014689","title":"凯信远达盘中异动 早盘大幅下挫5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490014689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490014689?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:00","pubTimestamp":1733842859,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时00分，凯信远达股票出现波动，股价快速下挫5.66%。截至发稿，该股报3.67美元/股，成交量1443股，换手率0.01%，振幅4.11%。凯信远达股票所在的生物技术行业中，整体跌幅为1.04%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230059a1e3a5ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230059a1e3a5ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2490088677","title":"凯信远达下跌4.68%，报3.46美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490088677","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490088677?lang=zh_cn&edition=full","pubTime":"2024-12-10 04:36","pubTimestamp":1733776582,"startTime":"0","endTime":"0","summary":"12月10日，凯信远达(CASI)盘中下跌4.68%，截至04:36，报3.46美元/股，成交22.42万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/10043646193339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2490773710","title":"凯信远达盘中异动 快速拉升6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773710?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:33","pubTimestamp":1733754823,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时33分，凯信远达股票出现波动，股价急速上涨6.89%。截至发稿，该股报3.88美元/股，成交量3879股，换手率0.03%，振幅6.89%。凯信远达股票所在的生物技术行业中，整体涨幅为0.19%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223344a1e0a964&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223344a1e0a964&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2489237481","title":"凯信远达上涨12.17%，报3.152美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489237481","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489237481?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:56","pubTimestamp":1733500595,"startTime":"0","endTime":"0","summary":"12月6日，凯信远达(CASI)盘中上涨12.17%，截至23:56，报3.152美元/股，成交4.02万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/06235646125714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2489728237","title":"凯信远达股价拉升12.17% 市值涨143.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489728237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489728237?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:56","pubTimestamp":1733500580,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时56分，凯信远达股票出现异动，股价急速上涨12.17%。截至发稿，该股报3.15美元/股，成交量1.226万股，换手率0.08%，振幅2.49%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.69%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235620a1d99929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235620a1d99929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2489685844","title":"凯信远达盘中异动 股价大跌8.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489685844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489685844?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:51","pubTimestamp":1733410306,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时51分，凯信远达股票出现异动，股价快速跳水8.63%。截至发稿，该股报3.13美元/股，成交量6291股，换手率0.04%，振幅6.14%。凯信远达股票所在的生物技术行业中，整体涨幅为0.31%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205225146a1d6a4c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205225146a1d6a4c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2489457579","title":"凯信远达下跌4.97%，报3.25美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457579","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457579?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:37","pubTimestamp":1733409424,"startTime":"0","endTime":"0","summary":"12月5日，凯信远达(CASI)盘中下跌4.97%，截至22:37，报3.25美元/股，成交1.48万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/05223746078464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2488190812","title":"凯信远达盘中异动 早盘大幅下跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488190812?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:02","pubTimestamp":1733324577,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时02分，凯信远达股票出现异动，股价急速跳水5.74%。截至发稿，该股报3.37美元/股，成交量6154股，换手率0.04%，振幅5.04%。凯信远达股票所在的生物技术行业中，整体涨幅为0.04%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423025798e55e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423025798e55e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2488925886","title":"凯信远达下跌5.78%，报3.72美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488925886","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488925886?lang=zh_cn&edition=full","pubTime":"2024-12-04 01:11","pubTimestamp":1733245911,"startTime":"0","endTime":"0","summary":"12月4日，凯信远达(CASI)盘中下跌5.78%，截至01:11，报3.72美元/股，成交11.7万美元。财务数据显示，截至2024年09月30日，凯信远达收入总额1518.1万美元，同比减少43.78%；归母净利润-2488.8万美元，同比减少19.18%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/04011145980579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2488932925","title":"凯信远达盘中异动 急速跳水5.78%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488932925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488932925?lang=zh_cn&edition=full","pubTime":"2024-12-04 01:11","pubTimestamp":1733245901,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日01时11分，凯信远达股票出现异动，股价大幅下挫5.78%。截至发稿，该股报3.72美元/股，成交量2.9262万股，换手率0.19%，振幅7.35%。凯信远达股票所在的生物技术行业中，整体跌幅为0.48%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204011142abf34345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204011142abf34345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.casipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.1479},{"period":"1month","weight":-0.4962},{"period":"3month","weight":-0.5904},{"period":"6month","weight":-0.276},{"period":"1year","weight":-0.6045},{"period":"ytd","weight":-0.6299}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"凯信远达医药公司于1991年注册成立，是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司，专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司，致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法，这将扩大血液学/肿瘤学特许经营权。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.175785},{"month":2,"riseRate":0.357143,"avgChangeRate":-0.007195},{"month":3,"riseRate":0.321429,"avgChangeRate":0.000453},{"month":4,"riseRate":0.392857,"avgChangeRate":0.035566},{"month":5,"riseRate":0.25,"avgChangeRate":0.051764},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.0196},{"month":7,"riseRate":0.241379,"avgChangeRate":-0.061023},{"month":8,"riseRate":0.310345,"avgChangeRate":-0.030773},{"month":9,"riseRate":0.482759,"avgChangeRate":0.008222},{"month":10,"riseRate":0.62069,"avgChangeRate":0.096357},{"month":11,"riseRate":0.37931,"avgChangeRate":0.031415},{"month":12,"riseRate":0.241379,"avgChangeRate":-0.10009}],"exchange":"NASDAQ","name":"凯信远达","nameEN":"CASI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯信远达,CASI,凯信远达股票,凯信远达股票老虎,凯信远达股票老虎国际,凯信远达行情,凯信远达股票行情,凯信远达股价,凯信远达股市,凯信远达股票价格,凯信远达股票交易,凯信远达股票购买,凯信远达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}